Antibiotics are being prescribed to prevent secondary bacterial infection because COVID-19 itself is an immunocompromised state and almost every COVID-19 sick patient is getting steroids which can further suppress immunity increasing the chances of secondary bacterial infection.
Facts:
1. Antibiotics cannot kill viruses, so they are not the definite treatment for viral pneumonia.
2. Antibiotics can kill normal bacterial flora in our body and then in such ‘immunocompromised state’ opportunistic microbes can take their place.
3. A retrospective small scale cohort study hypothesized that it’s ‘clinician’s anxiety’ over the possibility of concurrent or developing bacterial respiratory tract infections driving them to use antibiotics in cases of viral pneumonias.
Pitfalls of this study were, its small scale and retrospective nature. (Infect Control Hosp Epidemiol. 2010 November; 31(11): 1177–1183).
4. A study published in 2019 concluded that microbiota i.e., normal gut microbial flora drives an interferon (IFN) signature in lung stroma cells. These increased IFN signature impedes early influenza virus replication in lung epithelia. But the use of antibiotics reduces the IFN signature and facilitate early virus replication. (Bradley et al., 2019, Cell Reports 28, 245–256).
5. Even there is no data which shows that acute high doses of steroid use are associated with increase risk of bacterial infections.
Gibbs RC et al studied influence of prophylactic use of antibiotics on the incidence of staphylococcic infection in patients treated with steroids in the dermatological wards. They concluded that prophylactic addition of antibiotics certainly does not always succeed in preventing infection and may, in some cases, convert a potential hazard into reality. (JAMA. 1960;172(1):11-12. doi:10.1001/jama.1960)
RCTs of corticosteroid use in rheumatic diseases have not reported an increased risk of infection but observational studies have found a consistently elevated risk of infections (both serious and opportunistic). Of course, RCTs are considered more reliable when one has to draw some conclusion. (Rheum Dis Clin North Am. 2016 February; 42(1): 157–176.)
So, its time to re-think on extensive empirical antibiotics use.